Your browser doesn't support javascript.
loading
Hepatitis C antibody prevalence and active hepatitis C infection in HIV-negative gay, bisexual, and other men who have sex with men in Barcelona and Madrid, Spain (March 2018-March 2021).
Palma, David; Alarcón, Miguel; García de Olalla, Patricia; Guerras, Juan-Miguel; Pericas, Carles; García, Jorge; Barberá, María Jesús; Ayerdi, Oscar; Vera García, Mar; Román-Urrestarazu, Andrés; Belza, María José; Rius, Cristina.
Afiliação
  • Palma D; Consorcio de Investigación Biomédica en Red en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
  • Alarcón M; Servei d'Epidemiología, Agència de Salut Pública de Barcelona, Barcelona, Spain.
  • García de Olalla P; International Health Department, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherland.
  • Guerras JM; Consorcio de Investigación Biomédica en Red en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
  • Pericas C; Servei d'Epidemiología, Agència de Salut Pública de Barcelona, Barcelona, Spain.
  • García J; Department of Paediatrics, Obstetrics and Gynecology and Preventive Medicine, Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.
  • Barberá MJ; Consorcio de Investigación Biomédica en Red en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
  • Ayerdi O; Servei d'Epidemiología, Agència de Salut Pública de Barcelona, Barcelona, Spain.
  • Vera García M; Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (IRB Sant Pau), Barcelona, Spain.
  • Román-Urrestarazu A; Consorcio de Investigación Biomédica en Red en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain.
  • Belza MJ; Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Madrid, Spain.
  • Rius C; Servei d'Epidemiología, Agència de Salut Pública de Barcelona, Barcelona, Spain.
IJID Reg ; 8: 95-104, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37554356
ABSTRACT

Objectives:

Hepatitis C virus (HCV) has been recognized as a sexually transmitted infection (STI) in HIV-positive men who have sex with men (MSM), with an increased notification in HIV-negative MSM. The aim of this study was to determine the prevalence of HCV antibody and active HCV infection in HIV-negative gay, bisexual, and other MSM (GBMSM), and their characteristics, in Barcelona and Madrid, from March 2018 to March 2021.

Methods:

Cross-sectional study conducted on 3548 HIV-undiagnosed GBMSM, across four HIV/STI testing centers. Respondents submitted an online, self-administered questionnaire after consultation, which collected information on sociodemographics, sexual health history, HCV knowledge, and substance consumption. Prevalence of HCV antibodies was determined by a reactive result in a rapid anti-HCV test or enzyme-linked immunosorbent assay (ELISA), while active HCV infection was determined by participants who were also positive on an HCV-RNA test. Crude and adjusted Poisson analyses with robust variance are presented for both prevalence and active infection.

Results:

In total, 97.6% of participants (n = 3463) were HIV-negative. Of those, 18 were found to have HCV antibodies (0.52%), of which nine (0.26%) were also HCV-RNA positive. Those with HCV antibodies were associated to have lived with an HCV (+) person (adjusted prevalence ratio [APR] 7.84, [95% confidence interval 2.50-24.53]), using injectable drugs for sex (APR 6.92, [1.20-39.79]) and testing positive for an STI in the previous year (APR 4.06, [1.09-15.12]). Presenting an active infection was strongly associated with a previous HCV diagnosis (APR 100.82 [22.16-458.76]), sexualized injectable drug use (APR 17.53 [2.70-113.76]), and sharing douching material (APR 7.45, [2.12-25.95]).

Conclusion:

Sexual practices with a higher risk of bleeding and sexualized drug use, particularly sexualized injectable drug use, were associated with higher rates of HCV diagnosis in GBMSM. Identifying these practices during consultation, contact tracing new cases and regularly testing those with a previous history of HCV, will facilitate HCV eradication.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: IJID Reg Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: IJID Reg Ano de publicação: 2023 Tipo de documento: Article